Patents by Inventor Kenji Kishihara

Kenji Kishihara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD45 disrupted nucleic acid
    Patent number: 6664107
    Abstract: A mammal lacking expression of particular CD45 isoform in certain cells of the immune system is provided. The mammal may optionally contain a transgene encoding the CD45RO isoform. Also provided are methods of using these mammals.
    Type: Grant
    Filed: February 2, 1994
    Date of Patent: December 16, 2003
    Assignee: Ontario Cancer Institute, University Health Network
    Inventors: Tak Wah Mak, Kenji Kishihara